Literature DB >> 11584108

Helicobacter pylori: ulcers and more: the beginning of an era.

B E Lacy1, J Rosemore.   

Abstract

Helicobacter pylori (H. pylori) may be found in up to 50% of the world's population, making it the most common infectious disease worldwide. H. pylori is a gram-negative, microaerophilic rod with flagella and normally resides in the stomach. It can be diagnosed endoscopically, via breath tests, or through a simple blood test. H. pylori can usually be eradicated with a combination of proton pump inhibitors and antibiotics. Although most people infected with this organism never develop a complication, H. pylori infection in others may produce significant mucosal inflammation leading to ulcers in the stomach and duodenum. H. pylori has also been recognized as a risk factor for the development of both gastric carcinoma and mucosal-associated lymphoid tumor. Although not widely known, H. pylori can also affect organ systems outside of the gastrointestinal tract. It is now apparent that H. pylori can infect the skin, liver and heart and that these infections may produce a number of different disease states. In addition, H. pylori infection can adversely affect the nutritional status of both children and adults. This article discusses the epidemiology and bacteriology of H. pylori, reviews the different methods of diagnosing and treating this common infection, and then focuses on the effects that H. pylori has on different organ systems within the body, including the nutritional status of those affected.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11584108     DOI: 10.1093/jn/131.10.2789S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  31 in total

1.  In vitro and in vivo activities of HPi1, a selective antimicrobial against Helicobacter pylori.

Authors:  Ekaterina Gavrish; Binu Shrestha; Chao Chen; Ida Lister; E Jeffrey North; Lei Yang; Richard E Lee; Angel Han; Bronwyn Williams; David Charnuska; Ken Coleman; Kim Lewis; Michael D LaFleur
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

2.  Helicobacter pylori and serum kynurenine-tryptophan ratio in patients with colorectal cancer.

Authors:  Ayse Basak Engin; Bensu Karahalil; Ali Esat Karakaya; Atilla Engin
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

3.  Motor fluctuations and Helicobacter pylori in Parkinson's disease.

Authors:  Karl-Erik Rahne; Carl Tagesson; Dag Nyholm
Journal:  J Neurol       Date:  2013-09-04       Impact factor: 4.849

4.  Symptom improvement after helicobacter pylori eradication in patients with functional dyspepsia-A multicenter, randomized, prospective cohort study.

Authors:  Sanping Xu; Xueming Wan; Xiaolan Zheng; Yali Zhou; Zhiqiang Song; Minghu Cheng; Yiqi Du; Xiaohua Hou
Journal:  Int J Clin Exp Med       Date:  2013-09-25

5.  Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors.

Authors:  Jed W Fahey; Xavier Haristoy; Patrick M Dolan; Thomas W Kensler; Isabelle Scholtus; Katherine K Stephenson; Paul Talalay; Alain Lozniewski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 6.  Dietary amelioration of Helicobacter infection.

Authors:  Jed W Fahey; Katherine K Stephenson; Alison J Wallace
Journal:  Nutr Res       Date:  2015-03-06       Impact factor: 3.315

7.  Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light.

Authors:  Michael R Hamblin; Jennifer Viveiros; Changming Yang; Atosa Ahmadi; Robert A Ganz; M Joshua Tolkoff
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

8.  A functional polymorphism in the interleukin-1 receptor-1 gene is associated with increased risk of Helicobacter pylori infection but not with gastric cancer.

Authors:  Steve Hartland; Julia L Newton; S Michael Griffin; Pete T Donaldson
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

9.  Helicobacter pylori Eradication Therapy in Nonulcer Dyspepsia is Beneficial.

Authors:  Mohammed Q Khan
Journal:  Saudi J Gastroenterol       Date:  2008-04       Impact factor: 2.485

10.  Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors.

Authors:  Keyvan Pedrood; Homa Azizian; Mohammad Nazari Montazer; Maryam Mohammadi-Khanaposhtani; Mohammad Sadegh Asgari; Mehdi Asadi; Saeed Bahadorikhalili; Hossein Rastegar; Bagher Larijani; Massoud Amanlou; Mohammad Mahdavi
Journal:  Sci Rep       Date:  2021-05-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.